Quarterly report pursuant to Section 13 or 15(d)

EQUITY (Details 1)

v3.21.1
EQUITY (Details 1) - $ / shares
6 Months Ended 12 Months Ended
Feb. 28, 2021
Aug. 31, 2020
Number of Options Outstanding    
Number of Options Outstanding 281,834  
Number of Options Granted 2,080,000  
Number of Options Exercised 0  
Number of Options Forfeited/canceled 0  
Number of Options Outstanding 2,361,834 281,834
Number of Options Exercisable 237,237  
Weighted Average Exercise Price Options Outstanding    
Weighted Average Exercise Price, Outstanding $ 3.57  
Weighted Average Exercise Price, Granted 2.54  
Weighted Average Exercise Price, Exercised 0  
Weighted Average Exercise Price, Forfeited/canceled 0  
Weighted Average Exercise Price, Outstanding 2.66 $ 3.57
Weighted Average Exercise Price, Exercisable $ 3.48  
Weighted Average Remaining Contractual life, Outstanding (in years) 9 years 9 months 7 days 8 years 10 months 24 days
Weighted Average Remaining Contractual life, Granted (in years) 10 years  
Weighted Average Remaining Contractual life, Exercisable (in years) 8 years 9 months